We strive to be the worldwide reference provider of organs preservation technologies. Our work is inspired by our commitment to consistently meeting customer and regulatory requirements, to delivering quality products and to providing an innovative and comprehensive offer for organ preservation.
Institut Georges Lopez, more often referred to as IGL, consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges.
We design, manufacture, and market proprietary and generic products for organ preservation classified as drugs or medical devices. Our products are essential for the success of organ transplantations.
IGL is wholly owned by GROUPE CAIR.
Georges Antoine Lopez
President
Delphine Allard
Chief Executive Officer
Matthieu Proutteau
Head Pharmacist
Alexandre Lopez
R&D Director
Guillaume Olive
Commercial Director
Michael D. Christ
Global Marketing Director
Michael Christ
Chief Executive Officer, Waters Medical Systems LLC
Humberto Sobrinho
General Manager, IGL America Latina
• European MDD
• ISO 13485
• ISO 9001
• French Pharmaceutical cGMP
